Charles Serhan
Professor Charles N. Serhan was born in New York City. Since 1995, Charles is the Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital (BWH) in Boston. He is the endowed Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine, Harvard University. Professor Serhan received the Bachelor of Science Degree in biochemistry (BS, 1978) from Stony Brook University, New York, and received the doctorate in experimental pathology and medical sciences (1982) from New York University (NYU) School of Medicine. From 1981 to June 1986, he was visiting scientist at the Karolinska Institutet, Stockholm, Sweden and post-doctoral fellow with Professor Bengt Samuelsson (Nobel Laureate 1982). In July 1986, Charles joined the faculty at BWH and Harvard Medical School, and in 1996 received the honorary degree from Harvard University. He also received the Honorary Degree of Doctor of Science,
University College of Dublin, Ireland.
Dr. Serhan was awarded an NIH MERIT Award (2000), the MacArthur Research Service Award in 2003, and the 2004 Outstanding Scientist Award in Inflammation Research at BioDefense. He delivered the 2005 NIH Kreshover Lecture and received the LSU Chancellor’s Award in Neuroscience in 2006, and in 2007 the Dart-New York University Biotechnology Outstanding Achievement Award. In 2008, he delivered the Sir John Vane (Nobel Laureate 1982) Memorial Lecture and was awarded the 2008 William Harvey Outstanding Scientist Medal. In 2010, he delivered the Kern Lecture “in recognition of outstanding research on lipids” and received the Society for Leukocyte Biology 2010 Bonazinga Award for “excellence in leukocyte research, SLB’s highest honor”. Dr. Serhan was elected Fellow of AAAS in 2011, delivered the Lawrence Tabak NIH-Lectureship for excellence in Oral Biology and the 2011 American College of Rheumatology Hench (Nobel Laureate) Lecture awarded by Mayo Clinic Hench Society, and was named Honorary Fellow from Queen Mary University London. He also gave the 2012 NIH/NCI Distinguished Lecture STARS in Nutrition and Cancer and the NIH STEPS lecture. He received the 2013 Journal of Lipid Research Lectureship Award, 2013 Mérieux Laureate Research Grant and the 2013 Oh Dang International Prize from the Korean Pharmaceutical Society in recognition of an internationally recognized scholar who has had a major impact on pharmaceutical research and related areas of life sciences. In 2014, he received the Sterling Award Visiting Professorship at Virginia Commonwealth Medical University.
Charles is a member of several scientific advisory boards including recent appointments (2013) to the Scientific Advisory Board of the Pasteur Institute, France and to the NIH Board of Scientific Counselors for the intramural research program of NIAAA, Rockville, MD.
Professor Serhan’s research interests include the structural elucidation of novel mediators in the resolution of acute inflammation and reperfusion injury and their impact in human disease. Recent studies focus on novel mechanisms in the resolution of inflammation and receptors for pro-resolving mediators. His discoveries include aspirin-triggered lipid mediators, the resolvins, protectins and maresins, and most recently their families of bioactive peptide-lipid conjugates in programmed resolution and homeostasis.
Dr. Serhan led the NIH Program Project “Molecular Mechanisms in Leukocyte-Mediated Tissue Injury” (P01-DE13499), and was Principal Investigator/Program Director of the Center grant entitled “Specialized Center for Oral Inflammation and Resolution” (P50-DE016191). He currently serves as Program Director/Principal Investigator of P01-GM095467 entitled “Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology”.
Dr. Serhan has authored >513 scholarly publications, 4 books and >348 awarded patents and delivered more than 50 Keynote and named lectures at International Scientific Meetings.
University College of Dublin, Ireland.
Dr. Serhan was awarded an NIH MERIT Award (2000), the MacArthur Research Service Award in 2003, and the 2004 Outstanding Scientist Award in Inflammation Research at BioDefense. He delivered the 2005 NIH Kreshover Lecture and received the LSU Chancellor’s Award in Neuroscience in 2006, and in 2007 the Dart-New York University Biotechnology Outstanding Achievement Award. In 2008, he delivered the Sir John Vane (Nobel Laureate 1982) Memorial Lecture and was awarded the 2008 William Harvey Outstanding Scientist Medal. In 2010, he delivered the Kern Lecture “in recognition of outstanding research on lipids” and received the Society for Leukocyte Biology 2010 Bonazinga Award for “excellence in leukocyte research, SLB’s highest honor”. Dr. Serhan was elected Fellow of AAAS in 2011, delivered the Lawrence Tabak NIH-Lectureship for excellence in Oral Biology and the 2011 American College of Rheumatology Hench (Nobel Laureate) Lecture awarded by Mayo Clinic Hench Society, and was named Honorary Fellow from Queen Mary University London. He also gave the 2012 NIH/NCI Distinguished Lecture STARS in Nutrition and Cancer and the NIH STEPS lecture. He received the 2013 Journal of Lipid Research Lectureship Award, 2013 Mérieux Laureate Research Grant and the 2013 Oh Dang International Prize from the Korean Pharmaceutical Society in recognition of an internationally recognized scholar who has had a major impact on pharmaceutical research and related areas of life sciences. In 2014, he received the Sterling Award Visiting Professorship at Virginia Commonwealth Medical University.
Charles is a member of several scientific advisory boards including recent appointments (2013) to the Scientific Advisory Board of the Pasteur Institute, France and to the NIH Board of Scientific Counselors for the intramural research program of NIAAA, Rockville, MD.
Professor Serhan’s research interests include the structural elucidation of novel mediators in the resolution of acute inflammation and reperfusion injury and their impact in human disease. Recent studies focus on novel mechanisms in the resolution of inflammation and receptors for pro-resolving mediators. His discoveries include aspirin-triggered lipid mediators, the resolvins, protectins and maresins, and most recently their families of bioactive peptide-lipid conjugates in programmed resolution and homeostasis.
Dr. Serhan led the NIH Program Project “Molecular Mechanisms in Leukocyte-Mediated Tissue Injury” (P01-DE13499), and was Principal Investigator/Program Director of the Center grant entitled “Specialized Center for Oral Inflammation and Resolution” (P50-DE016191). He currently serves as Program Director/Principal Investigator of P01-GM095467 entitled “Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology”.
Dr. Serhan has authored >513 scholarly publications, 4 books and >348 awarded patents and delivered more than 50 Keynote and named lectures at International Scientific Meetings.
less
Interests
Uploads
Papers by Charles Serhan